ChemExpress

Established in 2006, Shanghai Haoyuan ChemExpress Co., Ltd. is headquartered in Shanghai, China. Today, ChemExpress operates six R&D centers and four manufacturing facilities, supporting global pharmaceutical and biotech partners across the full drug development lifecycle.
ChemExpress provides end-to-end CRO and CDMO services spanning small molecules, biologics, and new modalities, including ADCs/XDCs, peptides, and PROTACs. Our comprehensive platform covers the research, development, and manufacturing of regulatory starting materials, novel building blocks & intermediates, reference standards, drug substances (DS) and drug products (DP), including solid, semi-solid, liquid, and lyophilized biologics. We support programs from early discovery, process optimization, GMP manufacturing, to commercialization.